 The United States Patent and Trademark Office has issued a notice of patent allowance to Indaptus Therapeutics Incs NASDAQ: INDP platform technology. The patent provides broad protection for applying the Companys platform technology alone and in combination with standards of care for the treatment and inhibition of hepatitis B virus HBV and human immunodeficiency virus HIV infections. 